drugset / Trial / NCT00005879
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
Phase 2
Completed
199 enrolled
University of Kansas Medical Center
National Cancer Institute (NCI) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of LY353381 may be an effective way to prevent the development of breast cancer in women who have hyperplasia. PURPOSE: Randomized phase II trial to study the effectiveness of LY353381 in preventing breast cancer in women who have hyperplasia.
Timeline
- Start
- 2000-08
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | arzoxifene | Other / unclassified | 20 mg | Oral |